Skip to main content
Biochemical Journal logoLink to Biochemical Journal
. 2001 Apr 15;355(Pt 2):509–515. doi: 10.1042/0264-6021:3550509

cyp7b1 catalyses the 7alpha-hydroxylation of dehydroepiandrosterone and 25-hydroxycholesterol in rat prostate.

C Martin 1, R Bean 1, K Rose 1, F Habib 1, J Seckl 1
PMCID: PMC1221764  PMID: 11284740

Abstract

Dehydroepiandrosterone (DHEA) is the most prominent circulating steroid in humans, and it is a precursor for sex-steroid synthesis in peripheral tissues, including the prostate. Recently, enzyme-mediated pre-receptor metabolism has been recognized as a key step in determining steroid action in vivo. Hydroxylation of 3beta-steroids at the 7alpha-position has been reported in rat and human prostate to be a major inhibitory pathway to sex-steroid synthesis/action. However, the molecular identity of the enzyme responsible is so far unknown. We recently described a novel cytochrome P450 enzyme, cyp7b1, strongly expressed in the hippocampus of rodent brain, which catalyses the metabolism of DHEA, pregnenolone and 25-hydroxycholesterol to 7alpha-hydroxy products. In the light of this new enzyme, we have examined its possible role in 7alpha-hydroxylation conversion in rat prostate. NADPH-dependent 7alpha-hydroxylation was confirmed for 3beta-hydroxysteroids including DHEA and androstenediol, as well as 25-hydroxycholesterol. Kinetic analysis yielded an apparent K(m) of 14+/-1 microM for 7alpha-hydroxylation of DHEA in the prostate gland, a value similar to that recorded for recombinant cyp7b1 enzyme [13.6 microM; Rose, Stapleton, Dott, Kieny, Best, Schwarz, Russell, Bjoorkheim, Seckl and Lathe (1997) Proc. Natl. Acad. Sci. U.S.A. 94, 4925-4930]. The V(max) value of the prostate was 46+/-2 pmol/min per mg, and this activity was inhibited by clotrimazole, a P450-enzyme blocker. Moreover, RNA analysis (reverse-transcription PCR, Northern blotting and in situ hybridization) revealed a high expression of cyp7b1 mRNA in the rat prostate, restricted to the epithelium, suggesting that cyp7b1 catalyses oxysterol 7alpha-hydroxylation in the prostate gland.

Full Text

The Full Text of this article is available as a PDF (199.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams J. B. Control of secretion and the function of C19-delta 5-steroids of the human adrenal gland. Mol Cell Endocrinol. 1985 Jun;41(1):1–17. doi: 10.1016/0303-7207(85)90138-8. [DOI] [PubMed] [Google Scholar]
  2. Akwa Y., Morfin R. F., Robel P., Baulieu E. E. Neurosteroid metabolism. 7 alpha-Hydroxylation of dehydroepiandrosterone and pregnenolone by rat brain microsomes. Biochem J. 1992 Dec 15;288(Pt 3):959–964. doi: 10.1042/bj2880959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Akwa Y., Sananès N., Gouézou M., Robel P., Baulieu E. E., Le Goascogne C. Astrocytes and neurosteroids: metabolism of pregnenolone and dehydroepiandrosterone. Regulation by cell density. J Cell Biol. 1993 Apr;121(1):135–143. doi: 10.1083/jcb.121.1.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Araneo B., Daynes R. Dehydroepiandrosterone functions as more than an antiglucocorticoid in preserving immunocompetence after thermal injury. Endocrinology. 1995 Feb;136(2):393–401. doi: 10.1210/endo.136.2.7835270. [DOI] [PubMed] [Google Scholar]
  5. Axelson M., Larsson O. 27-hydroxylated low density lipoprotein (LDL) cholesterol can be converted to 7alpha,27-dihydroxy-4-cholesten-3-one (cytosterone) before suppressing cholesterol production in normal human fibroblasts. Evidence that an altered metabolism of ldl cholesterol can underlie a defective feedback control in malignant cells. J Biol Chem. 1996 May 31;271(22):12724–12736. doi: 10.1074/jbc.271.22.12724. [DOI] [PubMed] [Google Scholar]
  6. Balmain A., Krumlauf R., Vass J. K., Birnie G. D. Cloning and characterisation of the abundant cytoplasmic 7S RNA from mouse cells. Nucleic Acids Res. 1982 Jul 24;10(14):4259–4277. doi: 10.1093/nar/10.14.4259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bartsch W., Kozák I., Gorenflos P., Becker H., Voigt K. D. Concentrations of 3 beta-hydroxy androgens in epithelium and stroma of benign hyperplastic and normal human prostate. Prostate. 1986;8(1):3–10. doi: 10.1002/pros.2990080103. [DOI] [PubMed] [Google Scholar]
  8. Bastianetto S., Ramassamy C., Poirier J., Quirion R. Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Res Mol Brain Res. 1999 Mar 20;66(1-2):35–41. doi: 10.1016/s0169-328x(99)00002-9. [DOI] [PubMed] [Google Scholar]
  9. Bean R., Seckl J. R., Lathe R., Martin C. Ontogeny of the neurosteroid enzyme Cyp7b in the mouse. Mol Cell Endocrinol. 2001 Mar 28;174(1-2):137–144. doi: 10.1016/s0303-7207(00)00443-3. [DOI] [PubMed] [Google Scholar]
  10. Chang H. C., Miyamoto H., Marwah P., Lardy H., Yeh S., Huang K. E., Chang C. Suppression of Delta(5)-androstenediol-induced androgen receptor transactivation by selective steroids in human prostate cancer cells. Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11173–11177. doi: 10.1073/pnas.96.20.11173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  12. Danenberg H. D., Ben-Yehuda A., Zakay-Rones Z., Friedman G. Dehydroepiandrosterone enhances influenza immunization in aged mice. Ann N Y Acad Sci. 1995 Dec 29;774:297–299. doi: 10.1111/j.1749-6632.1995.tb17391.x-i1. [DOI] [PubMed] [Google Scholar]
  13. Doostzadeh J., Cotillon A. C., Morfin R. Dehydroepiandrosterone 7alpha- and 7beta-hydroxylation in mouse brain microsomes. Effects of cytochrome P450 inhibitors and structure-specific inhibition by steroid hormones. J Neuroendocrinol. 1997 Dec;9(12):923–928. doi: 10.1046/j.1365-2826.1997.00661.x. [DOI] [PubMed] [Google Scholar]
  14. Doostzadeh J., Cotillon A. C., Morfin R. Hydroxylation of pregnenolone at the 7 alpha- and 7 beta- positions by mouse liver microsomes. Effects of cytochrome p450 inhibitors and structure-specific inhibition by steroid hormones. Steroids. 1998 Jul-Aug;63(7-8):383–392. doi: 10.1016/s0039-128x(98)00012-9. [DOI] [PubMed] [Google Scholar]
  15. Gemzik B., Green J., Parkinson A. Hydroxylation of 5 alpha-androstane-3 beta,17 beta-diol by rat prostate microsomes: effects of antibodies and chemical inhibitors of cytochrome P450 enzymes. Arch Biochem Biophys. 1992 Aug 1;296(2):355–365. doi: 10.1016/0003-9861(92)90585-k. [DOI] [PubMed] [Google Scholar]
  16. Isaacs J. T., McDermott I. R., Coffey D. S. Characterization of two new enzymatic activities of the rat ventral prostate: 5 alpha-androstane-3 beta, 17 beta-diol 6 alpha-hydroxylase and 5 alpha-androstane-3 beta, 17 beta-diol 7 alpha-hydroxylase. Steroids. 1979 Jun;33(6):675–692. doi: 10.1016/0039-128x(79)90116-8. [DOI] [PubMed] [Google Scholar]
  17. Jelinek D. F., Andersson S., Slaughter C. A., Russell D. W. Cloning and regulation of cholesterol 7 alpha-hydroxylase, the rate-limiting enzyme in bile acid biosynthesis. J Biol Chem. 1990 May 15;265(14):8190–8197. [PMC free article] [PubMed] [Google Scholar]
  18. Kalimi M., Shafagoj Y., Loria R., Padgett D., Regelson W. Anti-glucocorticoid effects of dehydroepiandrosterone (DHEA). Mol Cell Biochem. 1994 Feb 23;131(2):99–104. doi: 10.1007/BF00925945. [DOI] [PubMed] [Google Scholar]
  19. Kimonides V. G., Khatibi N. H., Svendsen C. N., Sofroniew M. V., Herbert J. Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1852–1857. doi: 10.1073/pnas.95.4.1852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kuiper G. G., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J. A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5925–5930. doi: 10.1073/pnas.93.12.5925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Labrie C., Belanger A., Labrie F. Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate. Endocrinology. 1988 Sep;123(3):1412–1417. doi: 10.1210/endo-123-3-1412. [DOI] [PubMed] [Google Scholar]
  22. Li-Hawkins J., Lund E. G., Bronson A. D., Russell D. W. Expression cloning of an oxysterol 7alpha-hydroxylase selective for 24-hydroxycholesterol. J Biol Chem. 2000 Jun 2;275(22):16543–16549. doi: 10.1074/jbc.M001810200. [DOI] [PubMed] [Google Scholar]
  23. Li Y. C., Wang D. P., Chiang J. Y. Regulation of cholesterol 7 alpha-hydroxylase in the liver. Cloning, sequencing, and regulation of cholesterol 7 alpha-hydroxylase mRNA. J Biol Chem. 1990 Jul 15;265(20):12012–12019. [PubMed] [Google Scholar]
  24. Martin C., Chapman K. E., Seckl J. R., Ashley R. H. Partial cloning and differential expression of ryanodine receptor/calcium-release channel genes in human tissues including the hippocampus and cerebellum. Neuroscience. 1998 Jul;85(1):205–216. doi: 10.1016/s0306-4522(97)00612-x. [DOI] [PubMed] [Google Scholar]
  25. Martin K. O., Reiss A. B., Lathe R., Javitt N. B. 7 alpha-hydroxylation of 27-hydroxycholesterol: biologic role in the regulation of cholesterol synthesis. J Lipid Res. 1997 May;38(5):1053–1058. [PubMed] [Google Scholar]
  26. McCormick D. L., Rao K. V. Chemoprevention of hormone-dependent prostate cancer in the Wistar-Unilever rat. Eur Urol. 1999;35(5-6):464–467. doi: 10.1159/000019880. [DOI] [PubMed] [Google Scholar]
  27. McCormick D. L., Rao K. V., Johnson W. D., Bowman-Gram T. A., Steele V. E., Lubet R. A., Kellof G. J. Exceptional chemopreventive activity of low-dose dehydroepiandrosterone in the rat mammary gland. Cancer Res. 1996 Apr 15;56(8):1724–1726. [PubMed] [Google Scholar]
  28. Miyamoto H., Yeh S., Lardy H., Messing E., Chang C. Delta5-androstenediol is a natural hormone with androgenic activity in human prostate cancer cells. Proc Natl Acad Sci U S A. 1998 Sep 15;95(19):11083–11088. doi: 10.1073/pnas.95.19.11083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Moore M. A., Thamavit W., Tsuda H., Sato K., Ichihara A., Ito N. Modifying influence of dehydroepiandrosterone on the development of dihydroxy-di-n-propylnitrosamine-initiated lesions in the thyroid, lung and liver of F344 rats. Carcinogenesis. 1986 Feb;7(2):311–316. doi: 10.1093/carcin/7.2.311. [DOI] [PubMed] [Google Scholar]
  30. Nephew K. P., Sheeler C. Q., Dudley M. D., Gordon S., Nayfield S. G., Khan S. A. Studies of dehydroepiandrosterone (DHEA) with the human estrogen receptor in yeast. Mol Cell Endocrinol. 1998 Aug 25;143(1-2):133–142. doi: 10.1016/s0303-7207(98)00128-2. [DOI] [PubMed] [Google Scholar]
  31. Noshiro M., Nishimoto M., Morohashi K., Okuda K. Molecular cloning of cDNA for cholesterol 7 alpha-hydroxylase from rat liver microsomes. Nucleotide sequence and expression. FEBS Lett. 1989 Oct 23;257(1):97–100. doi: 10.1016/0014-5793(89)81795-8. [DOI] [PubMed] [Google Scholar]
  32. Pashko L. L., Rovito R. J., Williams J. R., Sobel E. L., Schwartz A. G. Dehydroepiandrosterone (DHEA) and 3 beta-methylandrost-5-en-17-one: inhibitors of 7,12-dimethylbenz[a]anthracene (DMBA)-initiated and 12-O-tetradecanoylphorbol-13-acetate (TPA)-promoted skin papilloma formation in mice. Carcinogenesis. 1984 Apr;5(4):463–466. doi: 10.1093/carcin/5.4.463. [DOI] [PubMed] [Google Scholar]
  33. Poortman J., Vroegindewey-Jie D., Thijssen J. H., Schwarz F. Relative binding affinity of androstane and C-19-nor-androstane-steroids for the estradiol-receptor in human myometrial and mammary cancer tissue. Mol Cell Endocrinol. 1977 Jul;8(1):27–34. doi: 10.1016/0303-7207(77)90015-6. [DOI] [PubMed] [Google Scholar]
  34. Rao K. V., Johnson W. D., Bosland M. C., Lubet R. A., Steele V. E., Kelloff G. J., McCormick D. L. Chemoprevention of rat prostate carcinogenesis by early and delayed administration of dehydroepiandrosterone. Cancer Res. 1999 Jul 1;59(13):3084–3089. [PubMed] [Google Scholar]
  35. Rose K. A., Stapleton G., Dott K., Kieny M. P., Best R., Schwarz M., Russell D. W., Björkhem I., Seckl J., Lathe R. Cyp7b, a novel brain cytochrome P450, catalyzes the synthesis of neurosteroids 7alpha-hydroxy dehydroepiandrosterone and 7alpha-hydroxy pregnenolone. Proc Natl Acad Sci U S A. 1997 May 13;94(10):4925–4930. doi: 10.1073/pnas.94.10.4925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Schaffner C. P. Prostatic cholesterol metabolism: regulation and alteration. Prog Clin Biol Res. 1981;75A:279–324. [PubMed] [Google Scholar]
  37. Schwartz A. G. Inhibition of spontaneous breast cancer formation in female C3H(Avy/a) mice by long-term treatment with dehydroepiandrosterone. Cancer Res. 1979 Mar;39(3):1129–1132. [PubMed] [Google Scholar]
  38. Schwarz M., Lund E. G., Lathe R., Björkhem I., Russell D. W. Identification and characterization of a mouse oxysterol 7alpha-hydroxylase cDNA. J Biol Chem. 1997 Sep 19;272(38):23995–24001. doi: 10.1074/jbc.272.38.23995. [DOI] [PubMed] [Google Scholar]
  39. Stapleton G., Steel M., Richardson M., Mason J. O., Rose K. A., Morris R. G., Lathe R. A novel cytochrome P450 expressed primarily in brain. J Biol Chem. 1995 Dec 15;270(50):29739–29745. doi: 10.1074/jbc.270.50.29739. [DOI] [PubMed] [Google Scholar]
  40. Sundin M., Warner M., Haaparanta T., Gustafsson J. A. Isolation and catalytic activity of cytochrome P-450 from ventral prostate of control rats. J Biol Chem. 1987 Sep 5;262(25):12293–12297. [PubMed] [Google Scholar]
  41. Weisser H., Krieg M. Lipid composition in epithelium and stroma of human benign prostatic hyperplasia. Prostate. 1997 Jan 1;30(1):41–46. doi: 10.1002/(sici)1097-0045(19970101)30:1<41::aid-pros6>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  42. Wu Z., Martin K. O., Javitt N. B., Chiang J. Y. Structure and functions of human oxysterol 7alpha-hydroxylase cDNAs and gene CYP7B1. J Lipid Res. 1999 Dec;40(12):2195–2203. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES